On 23 February 2012 at 12.00 noon, Professor Keith Campbell, the scientist who cloned Dolly the sheep, will deliver a lecture in the Conference Centre of the Copernicus Science Centre. Admission is free, but entrance tickets or invitations are required. The persons interested in attending the lecture can collect entrance tickets (until 6.00 p.m. of 22 February 2012) at the ticket offices of our Planetarium.
Professor Keith Campbell (born in 1954) is a biologist specialising in cell life cycle. He has been working scientifically for thirty years, out of which 14 devoted to embryology. Before that, he was engaged, among others, in research on the development of cancer cells.
His doctoral dissertation concerned the factors that influence behaviour of the cell nucleus during embryonic development in frogs. In 1991, he joined the Scottish Roslin Institute, where his knowledge of the control of cell life cycle was used to generate mammalian embryos by nuclear transfer. In 1995, these studies led to creation of two sheep – Megan and Morag – the first mammals cloned using nuclei taken from differentiated cells.
In 1996, further research in this area resulted in the birth of the famous Dolly the sheep – the first mammal cloned from somatic cells collected from an adult animal.
After that, Professor Keith Campbell began his cooperation with the biotechnology company PPL Therapeutics, which resulted in improved methods of cloning animals. He also created genetically modified animals – sheep that produced human proteins in their milk and pigs whose organs were to be used for xenotransplantations.
Since 1999, Professor Keith Campbell has worked at the University of Nottingham, where he conducts basic research on epigenetic programming of the structure of chromatin and the nucleus in control and development of cell differentiation.
Keith Campbell, winner of prestigious awards, is a member of scientific boards of several biotechnology companies and research institutes around the world, including PPL Therapeutics (United Kingdom, USA), Advanced Cell Technologies (USA), The Gene Centre (Germany), The Human Genome Centre, and University of Sao Paulo (Brazil).